Efficacy Study of Biophilia Tracker Bioresonance Therapy in the Treatment of Chronic Nonspecific Pulmonary Diseases

This study aims to investigate the clinical efficacy of Biophilia Tracker bioresonance therapy for certain forms of chronic nonspecific pulmonary diseases. Based on the principles of quantum physics and energy medicine, this therapy captures the unique frequencies of human cells and organs, analyzes functional imbalances in the body, and emits corrective frequencies to restore energy balance, thereby assisting in improving the function of damaged tissues. The treatment process is standardized and systematic, consisting of three main phases: pre-treatment preparation, core treatment implementation, and post-treatment consolidation, as detailed below.
In the pre-treatment preparation phase, patients undergo a comprehensive assessment, including detailed medical history collection and complete pulmonary examinations. The specific type and severity of conditions such as bronchial asthma and chronic bronchitis are identified, and contraindications are excluded. Meanwhile, the Biophilia Tracker device records the baseline biofrequencies of the patient’s lungs and entire body cells to establish a personalized frequency profile, which serves as a reference for subsequent treatment to ensure accuracy and safety. This phase aligns with the comprehensive evaluation principles used before biofeedback therapy, focusing on precise understanding of the patient’s physiological status.
The core treatment phase is critical to the entire procedure. Patients remain in a quiet, comfortable environment in a relaxed state, free from external interference. Using the Biophilia Tracker, the therapist compares the patient’s biofrequencies with the normal biofrequencies of healthy lungs, accurately identifying frequency imbalances associated with lesions such as airway inflammation and impaired ventilation. The device then emits corrective resonant frequencies matching the affected areas. Through energy transmission and conversion, it restores frequency balance in lung cells and airway tissues, relieves airway inflammation, improves ventilation, and helps repair damaged tissue function. This process follows the core logic of bioresonance—“resonance and harmonization”—and shares similarities with the energy transmission principles of multi-signal magnetic resonance therapy.Each session typically lasts 20–50 minutes, administered at least 5 times per week, with a basic course of 2 weeks. The exact duration and number of sessions are adjusted dynamically according to disease severity to maintain sustained therapeutic effects. The entire procedure is non-invasive and painless, similar to gentle energy conditioning, without injections or surgical intervention, and is well-tolerated by patients.
In the post-treatment consolidation phase, the therapist re-examines the patient’s biofrequencies, compares changes before and after treatment, evaluates clinical improvements, records relevant data, and documents results in medical records for follow-up. Patients are also instructed on daily precautions to avoid triggers of pulmonary disease and may perform simple relaxation exercises to enhance outcomes. Some patients require additional consolidation sessions based on recovery to further stabilize pulmonary function, reduce the risk of recurrence, and achieve long-term therapeutic effects.
The study specifically included patients with bronchial asthma, chronic non-obstructive bronchitis, and chronic obstructive bronchitis, covering the most common forms of chronic nonspecific pulmonary diseases. These conditions often present with airway inflammation and abnormal ventilation, and long-term stable control is sometimes difficult to achieve with conventional treatments. As an integrated energy therapy, bioresonance therapy provides a new approach for managing such disorders.
Clinical results show that after treatment with Biophilia Tracker bioresonance therapy, the overall effective rate reached 80%. This efficacy is consistent with that reported in similar studies of bioresonance therapy for chronic pulmonary diseases, indicating that this method can effectively improve clinical symptoms, assist in regulating respiratory function, and offer an effective supplementary strategy for the treatment of chronic nonspecific pulmonary diseases.